InsiderClue
Stocks · Health care · Surgical & Medical Instruments & Apparatus

Bioventus Inc.

BVS Clue Score54
United States Fiscal year ends December CIK 0001665988
$13.07 +2.96% Close, 9 Oct 2026
Alert on the numbers Alert on insider trades
Price $13.07 −4.98% Close, 9 Oct 2026

Closing prices at the end of each trading day, from 11 Feb 2021. Not a live quote. Adjusted for share splits, so the line has no step at a split; dividends are not added back. P/E and P/FCF are the market value over the last full fiscal year's net income or free cash flow, as public on each day, so they step once a year when the annual report comes out. A hatched band marks a stretch with none: a year of net loss, or of cash burnt.

Revenue and profit

What the business sells, and what is left of it. Point at a year for the detail.
RevenueOperating incomeNet income
Fiscal year 2019Revenue340.1Operating income31.2Net income6.9Fiscal year 2020Revenue321.2 −5.6%Operating income21.2Net income16.4 +139.5%Fiscal year 2021Revenue430.9 +34.2%Operating income12.1Net income19.4 +18.1%EPS, diluted−0.15Fiscal year 2022Revenue512.1 +18.8%Operating income−167.2Net income−158.7 −919.1%EPS, diluted−2.59Fiscal year 2023Revenue512.3 +0.0%Operating income−81.7Net income−156.2EPS, diluted−2.49Fiscal year 2024Revenue573.3 +11.9%Operating income−15.2Net income−36.1EPS, diluted−0.56Fiscal year 2025Revenue568.1 −0.9%Operating income54.0Net income22.7EPS, diluted0.33
FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Revenue 340.1 321.2 430.9 512.1 512.3 573.3 568.1
Growth −5.6% +34.2% +18.8% +0.0% +11.9% −0.9%
Operating income 31.2 21.2 12.1 −167.2 −81.7 −15.2 54.0
Net income 6.9 16.4 19.4 −158.7 −156.2 −36.1 22.7
Growth +139.5% +18.1% −919.1%
EPS, diluted n/a n/a −0.15 −2.59 −2.49 −0.56 0.33
Growth

Margins

How much of each dollar of revenue it keeps. Point at a year for the detail.
Gross marginOperating marginNet margin
Fiscal year 2019Gross margin73.3%Operating margin9.2%Net margin2.0%Free cash flow margin11.3%Fiscal year 2020Gross margin72.7%Operating margin6.6%Net margin5.1%Free cash flow margin17.2%Fiscal year 2021Gross margin70.3%Operating margin2.8%Net margin4.5%Free cash flow margin2.2%Fiscal year 2022Gross margin64.6%Operating margin−32.7%Net margin−31.0%Free cash flow margin−2.9%Fiscal year 2023Gross margin64.1%Operating margin−16.0%Net margin−30.5%Free cash flow margin1.6%Fiscal year 2024Gross margin67.7%Operating margin−2.7%Net margin−6.3%Free cash flow margin6.6%Fiscal year 2025Gross margin68.3%Operating margin9.5%Net margin4.0%Free cash flow margin12.7%
FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Gross margin 73.3% 72.7% 70.3% 64.6% 64.1% 67.7% 68.3%
Operating margin 9.2% 6.6% 2.8% −32.7% −16.0% −2.7% 9.5%
Net margin 2.0% 5.1% 4.5% −31.0% −30.5% −6.3% 4.0%
Free cash flow margin 11.3% 17.2% 2.2% −2.9% 1.6% 6.6% 12.7%

Cash flow

The cash the business makes, what it reinvests, and what it hands back. Point at a year for the detail.
Operating cash flowCapital expenditureFree cash flow
Fiscal year 2019Operating cash flow40.7Capital expenditure−2.3Free cash flow38.4Fiscal year 2020Operating cash flow71.8Capital expenditure−16.6Free cash flow55.2 +43.9%Fiscal year 2021Operating cash flow23.0Capital expenditure−13.5Free cash flow9.5 −82.8%Fiscal year 2022Operating cash flow−13.5Capital expenditure−1.5Free cash flow−15.0 −258.5%Fiscal year 2023Operating cash flow15.3Capital expenditure−7.4Free cash flow8.0Fiscal year 2024Operating cash flow38.8Capital expenditure−1.0Free cash flow37.8 +373.4%Fiscal year 2025Operating cash flow74.7Capital expenditure−2.6Free cash flow72.1 +90.8%
FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Operating cash flow 40.7 71.8 23.0 −13.5 15.3 38.8 74.7
Capital expenditure −2.3 −16.6 −13.5 −1.5 −7.4 −1.0 −2.6
Free cash flow 38.4 55.2 9.5 −15.0 8.0 37.8 72.1
Growth +43.9% −82.8% −258.5% +373.4% +90.8%

Balance sheet

What it holds against what it owes, at each year end. Point at a year for the detail.
CashTotal debt
Fiscal year 2019Cash64.5Fiscal year 2020Cash86.8Total debt188.4Net cash (debt)−101.5Fiscal year 2021Cash43.9Total debt357.7Net cash (debt)−313.7Shareholders’ equity458.9Debt to equity0.78Fiscal year 2022Cash30.2Total debt418.1Net cash (debt)−387.9Shareholders’ equity325.2Debt to equity1.29Fiscal year 2023Cash37.0Total debt394.8Net cash (debt)−357.9Shareholders’ equity173.6Debt to equity2.27Fiscal year 2024Cash41.6Total debt335.6Net cash (debt)−294.0Shareholders’ equity147.9Debt to equity2.27Fiscal year 2025Cash51.2Total debt294.0Net cash (debt)−242.7Shareholders’ equity184.1Debt to equity1.60
FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Cash 64.5 86.8 43.9 30.2 37.0 41.6 51.2
Total debt n/a 188.4 357.7 418.1 394.8 335.6 294.0
Net cash (debt) n/a −101.5 −313.7 −387.9 −357.9 −294.0 −242.7
Shareholders’ equity n/a n/a 458.9 325.2 173.6 147.9 184.1
Debt to equity n/a n/a 0.78 1.29 2.27 2.27 1.60

In millions of USD, except per-share figures and ratios. Fiscal years, as last filed with the SEC.

Financial statements FY2025 · 10-K

Ratios

Percentages worked out from the filed figures; debt to equity in times. Fiscal years ending December, each column as last filed with the SEC.
Click a line to chart it
Fiscal year FY2019 31 Dec 2019 FY2020 31 Dec 2020 FY2021 31 Dec 2021 FY2022 31 Dec 2022 FY2023 31 Dec 2023 FY2024 31 Dec 2024 FY2025 31 Dec 2025
Margins
73.3% 72.7% 70.3% 64.6% 64.1% 67.7% 68.3%
9.2% 6.6% 2.8% −32.7% −16.0% −2.7% 9.5%
2.8% 5.0% 2.2% −36.9% −23.6% −9.1% 4.5%
2.0% 5.1% 4.5% −31.0% −30.5% −6.3% 4.0%
11.3% 17.2% 2.2% −2.9% 1.6% 6.6% 12.7%
Spending
3.3% 3.5% 4.4% 4.7% 2.6% 2.4% 2.1%
58.4% 60.1% 59.0% 64.9% 59.3% 60.0% 55.3%
0.7% 5.2% 3.1% 0.3% 1.4% 0.2% 0.5%
16.3% 7.5% −20.7% n/a n/a n/a −6.1%
Returns
n/a n/a 4.2% −48.8% −90.0% −24.4% 12.3%
n/a 3.3% 1.6% −11.6% −19.3% −5.0% 3.3%
Balance and payout
n/a n/a 0.78 1.29 2.27 2.27 1.60
n/a 70.8% 50.4% 70.0% 72.7% 74.5% 66.6%